| Característica |
Objectiu de la convocatòria
The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired.
|
Característiques principals
Research proposals in the following topic areas are preferred:
Immunotherapy for the treatment of metastatic, lethal prostate cancer.
Targeted radionuclide therapy for advanced prostate cancer.
New systemic treatments for metastatic, lethal prostate cancer including those targeting the currently ‘undruggable’.
First-in-field research on new targets for systemic treatment of metastatic, lethal prostate cancer.
Mechanisms of resistance to current and investigational drugs targeting the androgen receptor and androgen axis, immune system and chemotherapy.
Correlative research around either clinical trials of novel agents or strategies or standard of care.
Developing or validating biomarkers that guide therapy in patients or further our understanding of the mechanisms by which therapies work.
Tumor microenvironment signaling related to cancer progression including the immune component.
New bioinformatics technologies for analysis of genomic data.
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.: 1670
Marta López: mlopez4@imim.es Ext.: 1576
|
Convocatòria (URL)
https://www.pcf.org/c/open-rfas/
On line aplication System: https://pcf.smartsimple.com
|
Requisits
The PCF Challenge Award Team:
Should be composed of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of this significant problem in prostate cancer research.
May be assembled from one institution, or several institutions.
Must embed at least one young investigator as an integral contributor to the team. The young investigator may hold the title of Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent and should be within six years following completion of a professional degree or clinical training such as MD, PhD, MD-PhD, DSc, ScD, DDM, DDS, DMD, MBBS, etc. He or she should have received no more than $200,000 in current direct research funding from all sources including institutional funds. Young investigators who have specifically received research support from the NCI, NIH, or DoD are still qualified and very much encouraged to apply.
Eligibility: Investigators representing non-profit academic research centers are eligible to apply for PCF Challenge Awards.
Investigators from for-profit companies and government-sponsored institutions, i.e., NIH, are ineligible.
|
Dotació
$ 1.000.000 per team
|
Durada
2 years
|
Documentació
Applications must be submitted online at: https://pcf.smartsimple.com
Supporting documents:
Scientific abstract
Statement of Originality
Research Proposal
NIH Biosketch
Budget
Clinical trial protocol and a timeline for activation of the clinical investigation: If applicable.
Supplemental Information (Optional)
|